|
Technical Discussion Insulin-like growth factors or
IGFs are peptide hormones secreted from many different cells. Their
designation as "insulin-like" originated from experiments in which
treatment of serum with antibodies to insulin failed to eliminate
all insulin activity; the remaining activity was ultimately ascribed
to the IGFs. Due to their growth promoting activity, they were
formerly called somatomedins.
|
Lay Interpretation
IGFs are Insulin like Growth Factors. |
IGFs, IGF Receptors and IGF-Binding Proteins
There are two principle IGFs referred to as IGF-I and IGF-II.
Each of these has a number of variant forms, resulting from use of
alternative gene promoters and alternative splicing. Structurally,
both IGFs resemble insulin in having two chains (A and B) connected
by disulfide bonds. Human IGF-I and IGF-II are, respectively, 70 and
67 amino acids in length.
In addition to two IGFs, there are three receptors that bind
IGFs with differing affinities:
- Type 1 IGF receptor: binds both IGF-I and IGF-II with
high affinity. This receptor has been identified in essentially
all tissues except liver, and virtually all of the biological
activities of the IGFs result from binding to the type 1
receptor.
- Type 2 IGF receptor: binds IGF-II with high affinity
and IGF-I with low affinity. It appears primarily to be involved
in clearance and degradation of IGF-II, although it may also
elicit some distinct signalling. This is also the cation-independent
mannose-6-phosphate receptor used for targeting mannosylated
enzymes to lysosomes.
- Insulin receptor: binds IGF-I with roughly 100-fold lower
affinity than insulin. High concentrations of IGF may stimulate
insulin signalling through this receptor.
Interestingly, the type 1 IGF and insulin receptors are very
similar structurally. In fact, in cells that express both receptors,
hybrid receptors appear to readily form, although the biological
consequences of these hybrids is not clear. |
IGFs come in two flavours,
IGF-1 and IGF-2. In humans, these peptides have 70 and 67 amino
acids per molecule respectively.
 |
|
A final important determinant of IGF activity is a family of
IGF-binding proteins. IGFs circulate in blood complexed [bound]
to these proteins, which not only extend the half-life of the
hormones, but modulate their interaction with receptors. To date, at
least six distinct IGF-binding proteins have been identified in
humans and rats. |
A type of IGF binding protein will often attach to
IGFs, extending its half life markedly. At least six different
variants of these have been identified. |